Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.
Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.
Iron chelation in the treatment of neurodegenerative diseases.
Multiparity in women with multiple sclerosis causes less long-term disability: No.
Proteomics of a conundrum: thoughts on addressing the aetiology vs. progression of Multiple Sclerosis.
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis.
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells.
The Cellular Prion Protein: A Player in Immunological Quiescence.
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Sexual dimorphism in the aged rat CD4+ T lymphocyte-mediated immune response elicited by inoculation with spinal cord homogenate.
Oligodendrocyte Development and Plasticity.
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases.
Early Postnatal Myelin Content Estimate of White Matter via T1w/T2w Ratio.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity.
Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients: An Open-Label Multicenter Study.
Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.

Pages